Navigation Links
ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
Date:1/8/2009

Webcast Presentation Scheduled for Wednesday, January 14, 2009 at 9:30 a.m. PT

BROOMFIELD, Colo. and SAN CARLOS, Calif., Jan. 8 /PRNewswire-FirstCall/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, and Nuvelo, Inc. (Nasdaq: NUVO) today announced that Richard Brewer, ARCA's president and chief executive officer, will present at the 27th Annual JPMorgan Healthcare Conference on Wednesday, January 14, 2009, at 9:30.a.m. PT in San Francisco.

ARCA biopharma and Nuvelo, Inc. announced on September 25, 2008 that they have entered into a definitive merger agreement, expected to create a cardiovascular-focused, late-stage biotechnology company. The presentation will discuss the assets of both companies, including ARCA's lead product Gencaro(TM) (bucindolol hydrochloride), a near-term commercial opportunity, as well as Nuvelo's mid-stage pipeline asset, novel short-acting anticoagulant NU172. In September 2008, the FDA formally accepted for filing ARCA's New Drug Application for Gencaro as a potential treatment for chronic heart failure. In accordance with the Prescription Drug User Fee Act (PDUFA), the FDA's goal is to complete and review all materials regarding Gencaro by May 31, 2009. The presentation will also discuss the structure and strategic plan of the combined company, pending the closing of the merger.

A live audio webcast of the presentation will be available online via the ARCA biopharma website at http://www.arcabiopharma.com or the Investor Relations portion of Nuvelo's website at http://www.nuvelo.com.

About ARCA biopharma

ARCA biopharma, Inc. is a privately held company focuse
'/>"/>

SOURCE ARCA biopharma, Inc. and Nuvelo, Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
2. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
3. Helix BioPharma Announces Q1 2009 Financial Results
4. McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries
5. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
6. XTL Biopharmaceuticals Implements Restructuring Plan
7. Nuvelo and ARCA biopharma Advance Toward Completion of Merger
8. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
9. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
10. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
11. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)... Executes Master Services Ag...mic QTbtb(sm) Solutions , ...iac Technologies, Inc., a leader in advanced cardi...nalysis, announced that it has executed a master s...pany covering both iCardiac,s Highly Automated QT ...
(Date:7/1/2009)... LONDON, July 1 Johnson & ...director of the Department of Molecular Biology at...ny, whose discoveries have led to novel cancer the...he winner of the 2009 Dr. Paul Janssen Award for B...rld-renowned scientists selected Dr. Ullrich, who ...
(Date:7/1/2009)... Single-dose of investigational sustained follicle...ctions of follitropin beta given over a one week p... Schering-Plough Corp., (...se III ENGAGE clinical trial demonstrating that a ... the class of sustained follicle stimulants, achie...
(Date:7/1/2009)... ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswir...) today announced that it expects to have top-line...52, the first of two pivotal Phase 3 clinical tria...-B(R)) in systemic lupus erythematosus (SLE). ,.../20080416/HGSLOGO ) , , Senior management wi...
Breaking Biology Technology:iCardiac Selected by Top 10 Pharmaceutical Company 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 3Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 4Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 2Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 3Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 4Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 5Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 6Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 7Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 8Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa 9Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus 2
... Editor,s note: This is the fifth in a series of a...chnology or biotechnology sectors. , , Madison,...lectual property is - the domain name, trademarks,... In this column, we will discuss the entity choic...useful at this early stage. , ,In today,s landscap...
... Madison, Wis. - Guess which governor said the ...me the energy capital of the world. , ,B. To lead,...y to power our lives and propel our state,s econom... even more boldly toward energy independence. , ,D... New Energy Economy. , ,E. The policies that helpe...
... Madison, Wis. - Aruna Biomedical , a Georgia-ba..., will relocate to Wisconsin if it can raise suffi...e confirmed. , ,The company, spun out of the Univ... funding commitments from the State of Wisconsin a...-based angel investment network, but it will need ...
... Madison, Wis. - Ed Meachen has an interconnected...one that would be impossible to imagine and execut...iate vice president of learning and information te...the University of Wisconsin-Superior someday sig...em,s flagship university, UW-Madison . , ,And why...
Other Biology Technology:Early Stage: Step 5 - Forming the entity 2Early Stage: Step 5 - Forming the entity 3Early Stage: Step 5 - Forming the entity 4Wisconsin will have plenty of competition in building the energy future 2Wisconsin will have plenty of competition in building the energy future 3Wisconsin will have plenty of competition in building the energy future 4Wisconsin tries to woo another stem cell company 2Wisconsin tries to woo another stem cell company 3CIO Leadership Series: Ed Meachen, University of Wisconsin System 2CIO Leadership Series: Ed Meachen, University of Wisconsin System 3CIO Leadership Series: Ed Meachen, University of Wisconsin System 4CIO Leadership Series: Ed Meachen, University of Wisconsin System 5
(Date:7/2/2009)...searchers from the National Oceanography Centre, S...f oceanographic knowledge to investigate the distr...ab. The results, published this week in the Jour...ing force behind the speciation and radiation of a...of millions of years of Earth,s history. , In d...
(Date:7/2/2009)...ientists are to study a group of proteins that are...uld hold the key to developing new types of antibi...rk and Leeds have been awarded 3.3m from the Biote...(BBSRC) to find out how a family of proteins known...before destroying them. , The team, led by Profe...
(Date:7/1/2009)...ndon, 1 July, 2009 Johnson & Johnson today announ...rtment of Molecular Biology at the Max Planck Inst...s have led to novel cancer therapies including Her...r. Paul Janssen Award for Biomedical Research. An...s selected Dr. Ullrich, who on September 8 will re...
(Date:7/1/2009)...Deleting two genes in mice responsible for repairi...al types of tumors, providing additional evidence ... cancer. That,s the conclusion of a recent study* ...titute of Standards and Technology (NIST), Oregon ...ork University School of Medicine (NYUSM). , Alt...
Breaking Biology News(10 mins):Evolution: Crabs go deep to avoid hot water 2Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Genetically engineered mice yield clues to 'knocking out' cancer 2Business scientific higher education groups laud President Obamas commitment to science 7914 1Business scientific higher education groups laud President Obamas commitment to science 7914 2Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 1Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 2Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 3Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 4Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 5Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills 42053 6Prune juice not necessary 3A New research should make bowel movements easier 42049 1Prune juice not necessary 3A New research should make bowel movements easier 42049 2How tumor cells move 7913 1How tumor cells move 7913 2
...The Quaking gene, first described as a mutation in...ress tumor formation and protect humans from cance... University and the University of Wisconsin has sh...growth by inhibiting production of a protein assoc...associated with severe birth defects and several c...
...Physicians prescribe antibiotics for more than hal...cted prevalence of strep throat, and used nonrecom...received an antibiotic prescription, according to ...itis (inflammation of the throat) accounts for 6 p...ysicians and pediatricians, according to backgroun...
...Researchers at Yale School of Medicine have demons...d been thought to alert the immune system to patho...ion and inflammation. , This has the potential to ...s underlying many skin disorders such as psoriasis...ound throughout the body and are extremely efficie...
...Habitual coffee drinking is not associated with an... an association was found with the consumption of ... November 9 issue of JAMA. , Approximately 50 mill... and the prevalence is increasing, according to ba...is a major risk factor for coronary heart disease,...
Other Biology News:Researchers discover new form of cancer gene regulation 2Researchers discover new form of cancer gene regulation 3Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Liquid. Phycoerythrin conjugate is in PBS, pH 7.4 containing 1% BSA and 0.1% sodium azide.
Supercoiled DNA Ladder is suitable for sizing supercoiled DNA from 2 to 16 kb by agarose gel electrophoresis (1). The bands can be visualized by ethidium bromide staining and may also be detected on
GIBCO RPMI Medium 1640; powder from Invitrogen
Rabbit polyclonal to Parathyroid Hormone Receptor 2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, corresponding to extracellular amino acids 99-116 of
Biology Products: